A. Makriyannis

Patrice D Cani, A. Makriyannis, Pauline Bottemanne, 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

How lipophilic cannabinergic ligands reach their receptor sites.

A. Makriyannis, Jianxin Guo, X. Tian, 2005, Prostaglandins & other lipid mediators.

A novel monoacylglycerol lipase inhibitor with analgesic and anti-inflammatory activity.

D. Hadjipavlou-Litina, A. Makriyannis, V. Magrioti, 2008, Bioorganic & medicinal chemistry letters.

Synthesis of Functionalized Cannabilactones

S. Nikas, A. Makriyannis, Yingpeng Liu, 2020, Molecules.

Oximes short-acting CB1 receptor agonists.

M. Malamas, J. Wood, Han Zhou, 2018, Bioorganic & medicinal chemistry.

3'-functionalized adamantyl cannabinoid receptor probes.

M. Tius, S. Nikas, Han Zhou, 2015, Journal of medicinal chemistry.

Inhibition of pain responses by activation of CB(2) cannabinoid receptors.

T. Vanderah, A. Makriyannis, F. Porreca, 2002, Chemistry and physics of lipids.

Effects of cannabinoids on preimplantation mouse embryo development and implantation are mediated by brain-type cannabinoid receptors.

S. Dey, A. Makriyannis, B. Paria, 1998, Biology of reproduction.

Evidence that anandamide‐signaling regulates human sperm functions required for fertilization

A. Makriyannis, A. Giuffrida, M. Mahony, 2002, Molecular reproduction and development.

Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis

A. Sanyal, F. Mirshahi, A. Makriyannis, 2001, Nature Medicine.

The interaction of cannabinoid receptor agonists, CP55940 and WIN55212-2 with membranes using solid state 2H NMR.

A. Makriyannis, De‐Ping Yang, S. Pavlopoulos, 2011, Biochimica et biophysica acta.

Design and synthesis of the CB1 selective cannabinoid antagonist AM281: A potential human SPECT ligand

N. Volkow, A. Makriyannis, R. Pertwee, 1999, AAPS PharmSci.

Bornyl- and isobornyl-Delta8-tetrahydrocannabinols: a novel class of cannabinergic ligands.

Anna L. Bowman, R. Duclos, A. Makriyannis, 2008, Journal of medicinal chemistry.

The role of halogen substitution in classical cannabinoids: A CB1 pharmacophore model

S. Nikas, Sonyuan Lin, J. Grzybowska, 2004, The AAPS Journal.

Enantiomeric resolution of a novel chiral cannabinoid receptor ligand.

M. Tius, G. Thakur, A. Makriyannis, 2002, Journal of biochemical and biophysical methods.

Inhibition of Inflammatory Hyperalgesia by Activation of Peripheral CB2 Cannabinoid Receptors

T. Vanderah, A. Makriyannis, F. Porreca, 2003, Anesthesiology.

Cannabinergic ligands.

G. Thakur, A. Makriyannis, S. Palmer, 2002, Chemistry and physics of lipids.

Molecular probes for the cannabinoid receptors.

A. Makriyannis, A. Khanolkar, S. Palmer, 2000, Chemistry and physics of lipids.

Preparation of iodine‐123 labeled AM251: A potential SPECT radioligand for the brain cannabinoid CB1 receptor

A. Makriyannis, R. Lan, S. Gatley, 1996 .

Azido‐ and Isothiocyanato‐Substituted Aryl Pyrazoles Bind Covalently to the CB1 Cannabinoid Receptor and Impair Signal Transduction

A. Makriyannis, A. Howlett, R. Lan, 2000, Journal of neurochemistry.

Identification of a potent and highly efficacious, yet slowly desensitizing CB1 cannabinoid receptor agonist

K. Mackie, C. Chavkin, A. Makriyannis, 2004, British journal of pharmacology.

The Cannabinoid Agonist WIN55,212-2 Suppresses Opioid-induced Emesis in Ferrets

T. Vanderah, A. Makriyannis, F. Porreca, 2001, Anesthesiology.

Natural and synthetic endocannabinoids and their structure-activity relationships.

A. Makriyannis, A. Khanolkar, S. Palmer, 2000, Current pharmaceutical design.

Unsaturated Side Chain β-11-Hydroxyhexahydrocannabinol Analogs

W. A. Hill, A. Makriyannis, A. Khanolkar, 1996 .

The conformational properties of the antineoplastic ether lipid 1-thiohexadecyl-2-O-methyl-S-glycero-3-phosphocholine.

T. Mavromoustakos, M. Koufaki, A. Makriyannis, 1996, Chemistry and physics of lipids.

Anandamide hydroxylation by brain lipoxygenase:metabolite structures and potencies at the cannabinoid receptor.

W. A. Hill, R. Eglen, A. Makriyannis, 1995, Biochimica et biophysica acta.

The medicinal chemistry of cannabinoids: an overview.

R. Rapaka, A. Makriyannis, 1987, NIDA research monograph.

The molecular features of membrane perturbation by anaesthetic steroids: a study using differential scanning calorimetry, small angle X-ray diffraction and solid state 2H NMR.

T. Mavromoustakos, A. Makriyannis, D. P. Yang, 1990, Ciba Foundation symposium.

Targeting the Endocannabinoid System for Neuroprotection: A 19F-NMR Study of a Selective FAAH Inhibitor Binding with an Anandamide Carrier Protein, HSA

Rishi Sharma, S. Nikas, A. Makriyannis, 2013, Journal of pharmaceutics & pharmacology.

Cannabilactones: a novel class of CB2 selective agonists with peripheral analgesic activity.

C. George, R. Duclos, G. Thakur, 2007, Journal of medicinal chemistry.

C1'-cycloalkyl side chain pharmacophore in tetrahydrocannabinols.

S. Nikas, S. O. Alapafuja, A. Tsotinis, 2007, Journal of medicinal chemistry.

Albumin enhances the diffusion of lipophilic drugs into the membrane bilayer.

A. Makriyannis, Jianxin Guo, X. Tian, 2005, Life sciences.

Adamantyl cannabinoids: a novel class of cannabinergic ligands.

J. Deschamps, C. George, G. Thakur, 2005, Journal of medicinal chemistry.

Synthesis of covalent probes for the radiolabeling of the cannabinoid receptor.

M. Tius, A. Makriyannis, Arun Ramamurthy, 2003, The Journal of organic chemistry.

High-resolution NMR and computer modeling studies of the cannabimimetic aminoalkylindole prototype WIN-55212-2.

A. Makriyannis, M. Eissenstat, J. Chen, 1999, Journal of medicinal chemistry.

Conformational studies on a diastereoisomeric pair of tricyclic nonclassical cannabinoids by NMR spectroscopy and computer molecular modeling.

A. Makriyannis, S. Pavlopoulos, C. Dimeglio, 1998, Journal of medicinal chemistry.

Topography and thermotropic properties of cannabinoids in brain sphingomyelin bilayers.

T. Mavromoustakos, A. Makriyannis, D. P. Yang, 1996, Life sciences.

Effects of the anesthetic steroid alphaxalone and its inactive delta 16-analog on the thermotropic properties of membrane bilayers. A model for membrane perturbation.

T. Mavromoustakos, A. Makriyannis, D. P. Yang, 1995, Biochimica et biophysica acta.

A novel electrophilic high affinity irreversible probe for the cannabinoid receptor.

J. Grzybowska, A. Makriyannis, X. Li, 1995, Life sciences.

Topography of alphaxalone and Δ16-alphaxalone in membrane bilayers containing cholesterol

T. Mavromoustakos, A. Makriyannis, De‐Ping Yang, 1994 .

Topography of alphaxalone and delta 16-alphaxalone in membrane bilayers containing cholesterol.

T. Mavromoustakos, A. Makriyannis, D. P. Yang, 1994, Biochimica et biophysica acta.

Solid state 2H-NMR as a method for determining the orientation of cannabinoid analogs in membranes

A. Makriyannis, A. Banijamali, De‐Ping Yang, 1991, Pharmacology Biochemistry and Behavior.

Small angle X-ray diffraction studies on the topography of cannabinoids in synaptic plasma membranes

T. Mavromoustakos, A. Makriyannis, De‐Ping Yang, 1991, Pharmacology Biochemistry and Behavior.

The orientation of (-)-delta 9-tetrahydrocannabinol in DPPC bilayers as determined from solid-state 2H-NMR.

H. Jarrell, A. Makriyannis, D. P. Yang, 1989, Biochimica et biophysica acta.

Mechanism of steroid anesthetic action: interactions of alphaxalone and delta 16-alphaxalone with bilayer vesicles.

S. Fesik, A. Makriyannis, 1983, Journal of medicinal chemistry.

Structural modifications of the cannabinoid side chain towards C3-aryl and 1',1'-cycloalkyl-1'-cyano cannabinoids.

A. Makriyannis, P. Fan, D. Papahatjis, 2006, Bioorganic & medicinal chemistry letters.

Novel 1′,1′-chain substituted Δ8-tetrahydrocannabinols

S. Nikas, A. Makriyannis, D. Papahatjis, 2002 .

Pharmacophoric requirements for cannabinoid side chains. Naphthoyl and naphthylmethyl substituted Δ8-tetrahydrocannabinol analogs†

A. Makriyannis, D. Papahatjis, T. Kourouli, 1996 .

Selectivity in aromatic fluorination. Introduction of fluorine probes into nabilone

W. A. Hill, M. Tius, A. Makriyannis, 1996 .

Common cannabimimetic pharmacophoric requirements between aminoalkyl indoles and classical cannabinoids.

A. Makriyannis, M. Eissenstat, X. Xie, 1995, Life sciences.

Classical/non-classical cannabinoid hybrids; stereochemical requirements for the southern hydroxyalkyl chain.

W. A. Hill, M. Tius, A. Makriyannis, 1995, Life sciences.

Studies of the conformational properties of the cannabimimetic aminoalkylindole pravadoline using NMR and molecular modeling

T. Mavromoustakos, A. Makriyannis, De‐Ping Yang, 1995 .

Conformationally restricted hybrids of CP-55,940 and HHC: Stereoselective synthesis and activity

M. Tius, A. Makriyannis, V. Abadji, 1994 .

CB1 cannabinoid receptor ligands.

S. Nikas, G. Thakur, A. Makriyannis, 2005, Mini reviews in medicinal chemistry.

C1'-Azacycloalkyl Hexahydrocannabinols.

M. Tius, S. Nikas, N. Shimada, 2017, The Journal of organic chemistry.

Novel conformationally restricted tetracyclic analogs of delta8-tetrahydrocannabinol.

A. Makriyannis, A. Khanolkar, P. Fan, 1999, Bioorganic & medicinal chemistry letters.

C-Attached aminoalkylindoles: potent cannabinoid mimetics

W. A. Hill, J. Abt, A. Makriyannis, 1996 .

Anesthetic steroid mobility in model membrane preparations as examined by high-resolution 1H and 2H NMR spectroscopy.

S. Fesik, A. Makriyannis, C. Dimeglio, 1991, Journal of medicinal chemistry.

United States Patent ( 10 ) Patent No . : US 7 , 666 , 867 B 2

A. Makriyannis, Rei-tsang Shiao, 2017 .

Hydrogen-Deuterium Exchange Mass Spectrometry to Study Protein Complexes.

T. Wales, A. Makriyannis, Roxana E. Iacob, 2018, Methods in molecular biology.

Synthesis and pharmacological properties of 11-hydroxy-3-(1',1'-dimethylheptyl)hexahydrocannabinol: a high-affinity cannabinoid agonist.

A. Makriyannis, D. R. Compton, B. Martin, 1994, Journal of medicinal chemistry.

Pharmacological evaluation of iodo and nitro analogs of Δ 8-THC and Δ 9-THC

S. Semus, Sonyuan Lin, J. Grzybowska, 1993, Pharmacology Biochemistry and Behavior.

Synthesis and anti-HIV Evaluation of Alkyl and Alkoxyethyl Phosphodiester AZT Derivatives

E. De Clercq, A. Tsotinis, J. Balzarini, 1995 .

Synthesis and antiretroviral evaluation of new alkoxy and aryloxy phosphate derivatives of 3'-azido-3'-deoxythymidine.

E. De Clercq, A. Tsotinis, J. Balzarini, 1996, Journal of medicinal chemistry.

Single crystal X-ray structures of the two 4-heptadecyl derivatives of (1R,5S)-3,6,8-trioxabicyclo[3.2.1]octane.

R. Duclos, L. Herbette, J. Moring, 1995, Chemistry and physics of lipids.

Bifunctional agents for reperfusion arrhythmias: novel hybrid vitamin E/class I antiarrhythmics.

P. Papazafiri, T. Calogeropoulou, M. Koufaki, 2003, Bioorganic & Medicinal Chemistry.

Regiospecifically deuterated (−)-Δ9-tetrahydrocannabivarins

S. Nikas, G. Thakur, A. Makriyannis, 2002 .

Synthesis of side chain specifically deuterated (-)-Δ9-tetrahydrocannabinols

S. Nikas, G. Thakur, A. Makriyannis, 2002 .

Conformational analysis of amphetamine in solution based on unambiguous assignment of the diastereotopic benzylic protons in the 1H NMR spectra

J. Knittel, A. Makriyannis, 1981 .

Syntheses of 1,2-di-O-palmitoyl-sn-glycero-3-phosphocholine (DPPC) and analogs with 13C- and 2H-labeled choline head groups.

R. Duclos, A. Makriyannis, S. Lin, 1997, Chemistry and physics of lipids.

Model Investigations for Vanadium-Protein Interactions. Synthetic, Structural, and Physical Studies of Vanadium(III) and Oxovanadium(IV/V) Complexes with Amidate Ligands.

A. Terzis, A. Makriyannis, A. Keramidas, 1996, Inorganic chemistry.

Classical/nonclassical hybrid cannabinoids: southern aliphatic chain-functionalized C-6beta methyl, ethyl, and propyl analogues.

M. Tius, A. Makriyannis, P. Fan, 1998, Journal of medicinal chemistry.

Novel and efficient one-step parallel synthesis of dibenzopyranones via Suzuki-Miyaura cross coupling.

A. Makriyannis, K. Vishnumurthy, 2010, Journal of combinatorial chemistry.

Intramolecular Heck reactions of aryl chlorides with alkynes

A. Makriyannis, Christopher L. Hamblett, L. Chapman, 2010 .

Azodicarboxylic acid esters as dealkylating agents.

A. Makriyannis, E. Smissman, 1973, The Journal of organic chemistry.

An unusual reactivity of BBr(3): Accessing tetrahydroisoquinoline units from N-phenethylimides.

A. Makriyannis, J. Selvakumar, C. Ramanathan, 2010, Organic & biomolecular chemistry.

Methoxy group conformations of phenyl methyl ethers in solution

S. Fesik, A. Makriyannis, 1982 .

Preparation of optically pure 4-(hydroxymethyl)-2-pentadecyl-1,3-dioxolanes and their corresponding phosphodiester ether lipid derivatives.

R. Duclos, A. Makriyannis, S. Lin, 2001, Chemistry and physics of lipids.

Syntheses of 2H- and 13C-labeled 1,2-di-O-hexadecyl-sn-glycero-3-phosphoethanolamines and 1,2-di-O-hexadecyl-sn-glycero-3-phosphocholines

R. Griffin, R. Duclos, A. Makriyannis, 1989 .

Deuterium NMR investigation of ether- and ester-linked phosphatidylcholine bilayers.

R. Griffin, A. Makriyannis, D. Siminovitch, 1985, Biochemistry.

A direct approach to the determination of the rotational barriers of the acetylcholine and choline molecules.

A. Makriyannis, H. Mautner, J. M. Theard, 1979, Biochemical pharmacology.

Heteroadamantyl cannabinoids.

Anna L. Bowman, M. Tius, J. Wood, 2010, Journal of medicinal chemistry.

The effect of cholesterol on lipid dynamics and packing in diether phosphatidylcholine bilayers. X-ray diffraction and 2H-NMR study.

R. Griffin, A. Makriyannis, D. Siminovitch, 1987, Biochimica et biophysica acta.

The Endocannabinoid System as a Target for Alkamides from Echinacea angustifolia Roots

R. Bauer, Ying Pei, W. Xu, 2005, Planta medica.

The conformation of the cytoplasmic helix 8 of the CB1 cannabinoid receptor using NMR and circular dichroism.

A. Makriyannis, Jianxin Guo, G. Choi, 2005, Biochimica et biophysica acta.

The conformational analysis of aromatic methoxyl groups from carbon-13 chemical shifts and spin-lattice relaxation times

J. Knittel, A. Makriyannis, 1979 .

Study of the topography of cannabinoids in model membranes using X-ray diffraction.

T Mavromoustakos, L. Herbette, T. Mavromoustakos, 1990, Biochimica et biophysica acta.

Derivative Spectroscopy in Conjunction with Thin Layer Chromatography Applied for Determination of Mixtures of Amino Acids in Baby Food.

A. Makriyannis, W. Hassan, M. Ayad, 1997 .

Nortropacocaine hydrochloride conformation in aqueous and hydrophobic media.

G. Hite, A. Makriyannis, 1979, Journal of Pharmacy and Science.

Novel tail and head group prostamide probes.

S. Nikas, C. Serhan, N. Chiang, 2015, Bioorganic & medicinal chemistry letters.

The conformation of (-) 8 α and (-) 8 β-hydroxy-δ9-tetrahydrocannabinols and their interactions with model membranes

T. Mavromoustakos, A. Makriyannis, C. V. D. Schyf, 1988 .

Conformational relationships between analogs of acetylcholine and those of local anesthetics in solution.

A. Makriyannis, H. Mautner, R. F. Sullivan, 1972, Proceedings of the National Academy of Sciences of the United States of America.

Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: Pain inhibition by receptors not present in the CNS

D. Cockayne, J. H. Law, T. Vanderah, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Novel adamantyl cannabinoids as CB1 receptor probes.

Anna L. Bowman, M. Caron, J. Deschamps, 2013, Journal of medicinal chemistry.

Mechanisms of local anesthetic action on the permeability of erythrocytes, leukocytes, and liposomes containing the erythrocyte anion channel protein.

A. Makriyannis, R. Sha’afi, M. B. Feinstein, 1977, Molecular pharmacology.

Compounds acting at the endocannabinoid and/or endovanilloid systems reduce hyperkinesia in a rat model of Huntington's disease

A. Makriyannis, V. Di Marzo, J. Fernández-Ruiz, 2003, Journal of neurochemistry.

Behavioral effects of the novel cannabinoid full agonist AM 411

J. Salamone, G. Thakur, A. Makriyannis, 2005, Pharmacology Biochemistry and Behavior.

Conformational study of lipophilic ligands in phospholipid model membrane systems by solution NMR.

S. Nikas, A. Makriyannis, Jianxin Guo, 2003, Journal of medicinal chemistry.

Alterations in red blood cell sugar transport by nanomolar concentrations of alkyl lysophospholipid.

R. Duclos, A. Makriyannis, A. Carruthers, 1990, Biochimica et biophysica acta.

Ligand based structural studies of the CB1 cannabinoid receptor.

A. Makriyannis, R. P. Picone, D. Fournier, 2002, The journal of peptide research : official journal of the American Peptide Society.

Antileishmanial ring-substituted ether phospholipids.

S. Grdadolnik, A. Tsotinis, A. Detsi, 2003, Journal of medicinal chemistry.

Effect of the cannabinoid receptor SPECT agent, AM 281, on hippocampal acetylcholine release from rat brain slices

N. Volkow, A. Makriyannis, R. Lan, 1997, Neuroscience Letters.

Amphipathic interactions of cannabinoids with membranes. A comparison between delta 8-THC and its O-methyl analog using differential scanning calorimetry, X-ray diffraction and solid state 2H-NMR.

T. Mavromoustakos, A. Makriyannis, K. Beshah, 1992, Biochimica et biophysica acta.

Differential scanning calorimetry and small angle x-ray diffraction study of the interaction of (R)-PAF, (R)-ET-18-OME and (R)-Lyso-PAF with model membranes.

J. Moring, A. Makriyannis, X. Xie, 1997, Life sciences.

The cannabinoid receptor antagonist SR-141716 does not readily antagonize open-field effects induced by the cannabinoid receptor agonist (R)-methanandamide in rats

N. DiPatrizio, A. Makriyannis, T. Järbe, 2003, Pharmacology Biochemistry and Behavior.

Characterization of the L lambda phase in trehalose-stabilized dry membranes by solid-state NMR and X-ray diffraction.

R. Griffin, G. Shipley, A. Makriyannis, 1989, Biochemistry.

Pharmacophoric requirements for the cannabinoid side chain. Probing the cannabinoid receptor subsite at C1'.

S. Nikas, Wei Xu, A. Makriyannis, 2003, Journal of medicinal chemistry.

Conformational analysis of the prototype nonclassical cannabinoid CP-47,497, using 2D NMR and computer molecular modeling.

A. Makriyannis, L. Melvin, D. P. Yang, 1994, Journal of medicinal chemistry.

C3-heteroaroyl cannabinoids as photolabeling ligands for the CB2 cannabinoid receptor.

Anna L. Bowman, M. Tius, Han Zhou, 2012, Bioorganic & medicinal chemistry letters.

Topography of tetrahydrocannabinol in model membranes using neutron diffraction.

K. R. Jeffrey, T. Mavromoustakos, A. Makriyannis, 1993, Biochimica et biophysica acta.

Small angle X-ray diffraction studies of (-)-delta 8-tetrahydrocannabinol and its O-methyl analog in membranes.

T. Mavromoustakos, A. Makriyannis, D. P. Yang, 1993, Life sciences.

Pharmacophoric requirements for cannabinoid side chains: multiple bond and C1'-substituted delta 8-tetrahydrocannabinols.

A. Makriyannis, A. Goutopoulos, D. Papahatjis, 1998, Journal of medicinal chemistry.

Conformational memories and the endocannabinoid binding site at the cannabinoid CB1 receptor.

F. Guarnieri, A. Makriyannis, D. Lynch, 2002, Journal of medicinal chemistry.

The Conformation, Location, and Dynamic Properties of the Endocannabinoid Ligand Anandamide in a Membrane Bilayer*

A. Makriyannis, Jianxin Guo, Fenmei Yao, 2005, Journal of Biological Chemistry.

Studies on phenethylamine hallucinogens. 2. Conformations of arylmethoxyl groups using 13C NMR.

J. Knittel, A. Makriyannis, 1981, Journal of medicinal chemistry.

Cannabinoid receptors as therapeutic targets.

S. Nikas, G. Thakur, A. Makriyannis, 2006, Current pharmaceutical design.

The perturbation of model membranes by (-)-delta 9-tetrahydrocannabinol. Studies using solid-state 2H- and 13C-NMR.

R. Griffin, A. Makriyannis, S. Das Gupta, 1990, Biochimica et biophysica acta.

Structure and orientation of the pore-forming peptide, melittin, in lipid bilayers.

A. Whittaker, B. Cornell, A. Makriyannis, 1994, Journal of molecular biology.

Conformational Analysis of the Opioid Phenylmorphan and Its 9α-Methyl Analogue in Solution Using High-Resolution Nuclear Magnetic Resonance Spectroscopy

M. Froimowitz, A. Makriyannis, C. Dimeglio, 1993, Pharmaceutical Research.

Crystal structure of the meta hydroxyl phenyl analog of α(+)-prodine

V. Cody, M. Froimowitz, A. Makriyannis, 1996 .

Chiral resolution of 1,3-dimethyl-4-phenylpiperidine derivatives using high-performance liquid chromatography with a chiral stationary phase.

M. Froimowitz, A. Makriyannis, A. Khanolkar, 1994, Journal of chromatography. A.

17β-estradiol (E2) in membranes: Orientation and dynamic properties.

R. Duclos, A. Makriyannis, D. Janero, 2016, Biochimica et biophysica acta.

17 β-estradiol ( E 2 ) in membranes : Orientation and dynamic properties

R. Duclos, A. Makriyannis, D. Janero, 2015 .

Interactions of angiotensin II with membranes using a combination of differential scanning calorimetry and 31P NMR spectroscopy

Thomas Mavromoustakos, J. Matsoukas, T. Mavromoustakos, 1996, Letters in Peptide Science.

Structural Chemistry Using NMR Spectroscopy, Pharmaceuticals

A. Makriyannis, S. Pavlopoulos, 2010 .

Synthesis and pharmacology of N-cyano-(beta-arylethyl)amines.

A. Makriyannis, E. Walaszek, E. Smissman, 1970, Journal of medicinal chemistry.

Inhibition of [3H]5-HT binding to rat brain membranes by psychotomimetic amphetamines.

A. Makriyannis, A. D. de Jong, D. Fournier, 1982, European journal of pharmacology.

Carbon-13 and proton magnetic resonance spectra of 2,4-disubstituted 3,3-diphenyltetrahydrofurans derived from isomethadone and isomethadol

A. Makriyannis, David A. Williams, 1979 .

CB2 cannabinoid receptor agonists: pain relief without psychoactive effects?

T. Vanderah, A. Makriyannis, F. Porreca, 2003, Current opinion in pharmacology.

Encyclopedia of Spectroscopy and Spectrometry, 2nd Edition

A. M. Pollard, A. D. Bain, Jimmy D Bell, 2010 .

Role of the NH2-terminal domain of angiotensin II (ANG II) and [Sar1]angiotensin II on conformation and activity. NMR evidence for aromatic ring clustering and peptide backbone folding compared with [des-1,2,3]angiotensin II.

T Mavromoustakos, G. Moore, J. Matsoukas, 1994, The Journal of biological chemistry.

Specific deuteration of phenols and aromatic ethers using boron trifluoride and deuterium oxide

A. Makriyannis, A. Banijamali, C. V. D. Schyf, 1987 .

Magnetically aligned bicelles to study the orientation of lipophilic ligands in membrane bilayers.

A. Makriyannis, R. Chari, Jianxin Guo, 2008, Journal of medicinal chemistry.

Binding between a distal C-terminus fragment of cannabinoid receptor 1 and arrestin-2.

A. Makriyannis, Shubhadra N. Singh, R. Mercier, 2011, Biochemistry.

Studies on the interaction of anesthetic steroids with phosphatidylcholine using 2H and 13C solid state NMR.

R. Griffin, A. Makriyannis, S. Das Gupta, 1986, Biochimica et biophysica acta.

Geometric requirements for membrane perturbation and anesthetic activity. Conformational analysis of alphaxalone and delta 16-alphaxalone and 2H NMR studies on their interactions with model membranes.

S. Fesik, A. Makriyannis, 1985, Molecular pharmacology.

MECHANISM OF STEROID ANESTHETIC ACTION: INTERACTIONS OF ALPHAXALONE AND Δ16-ALPHAXALONE WITH BILAYER VESICLES

S. Fesik, A. Makriyannis, 1983 .

Effects of anesthetics on sulfate transport in the red cell

S. Fesik, A. Makriyannis, Stephen W. Fesik, 1980, Journal of neuroscience research.

Small angle X-ray diffraction and differential scanning calorimetric studies on O-methyl-(-)-delta 8-tetrahydrocannabinol and its 5' iodinated derivative in membrane bilayers.

T. Mavromoustakos, A. Makriyannis, D. P. Yang, 1995, Biochimica et biophysica acta.

(R)-methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability.

A. Makriyannis, Sonyuan Lin, A. Makriyannis, 1994, Journal of medicinal chemistry.

PET studies in the primate brain and biodistribution in mice using (−)-5′-18 F-Δ 8-THC

A. Wolf, D. Schlyer, D. Schlyer, 1991, Pharmacology Biochemistry and Behavior.

123I-labeled AM251: a radioiodinated ligand which binds in vivo to mouse brain cannabinoid CB1 receptors.

N. Volkow, A. Makriyannis, A. Makriyannis, 1996, European journal of pharmacology.

3D-QSAR studies of arylpyrazole antagonists of cannabinoid receptor subtypes CB1 and CB2. A combined NMR and CoMFA approach.

Qian Liu, Xiang-Qun Xie, Junmei Wang, 2006, Journal of medicinal chemistry.

A novel monoacylglycerol lipase inhibitor with analgesic and anti-inflammatory activity.

D. Hadjipavlou-Litina, A. Makriyannis, V. Magrioti, 2008, Bioorganic & medicinal chemistry letters.

A New Ring-Forming Methodology for the Synthesis of Conformationally Constrained Bioactive Molecules

S. Nikas, A. Tsotinis, A. Makriyannis, 2001 .

High-performance liquid chromatographic determination of anandamide amidase activity in rat brain microsomes.

W. A. Hill, A. Makriyannis, Sonyuan Lin, 1996, Analytical biochemistry.

Effect of phenylmethylsulphonyl fluoride on the potency of anandamide as an inhibitor of electrically evoked contractions in two isolated tissue preparations.

A. Makriyannis, A. Makriyannis, R. Pertwee, 1995, European journal of pharmacology.

Structure activity correlations in the inhibition of brain synaptosomal 3H-norepinephrine uptake by phenethylamine analogs. The role of alpha-alkyl side chain and methoxyl ring substitutions.

A. Makriyannis, A. D. de Jong, P. Y. Sze, 1982, European journal of pharmacology.

The Conformational Properties of the Highly Selective Cannabinoid Receptor Ligand CP-55,940 (*)

A. Makriyannis, L. Melvin, Xiang-Qun Xie, 1996, The Journal of Biological Chemistry.

Solvent effects in the NMR spectra of cyano compounds.

A. Makriyannis, E. Smissman, 1970, Journal of pharmaceutical sciences.

Separation of Tetrahydrocannabinol Isomers by Reverse-Phase High Pressure Liquid Chromatography

A. Makriyannis, A. Banijamali, 1987 .

Studies on the thermotropic effects of cannabinoids on phosphatidylcholine bilayers using differential scanning calorimetry and small angle X-ray diffraction.

M. Trumbore, A. Makriyannis, De‐Ping Yang, 1996, Biochimica et biophysica acta.

Time course of the effects of different cannabimimetics on prolactin and gonadotrophin secretion: evidence for the presence of CB1 receptors in hypothalamic structures and their involvement in the effects of cannabimimetics.

A. Makriyannis, A. Makriyannis, J. Ramos, 1997, Biochemical pharmacology.